Five-year Follow-up of a Prospective Randomised Trial Comparing Ceramic-on-metal and Metal-on-metal Bearing Surfaces in Total Hip Arthroplasty
Overview
Orthopedics
Authors
Affiliations
Aims: The primary aim of this independent prospective randomised trial was to compare serum metal ion levels for ceramic-on-metal (CoM) and metal-on-metal (MoM) bearing surfaces in total hip arthroplasty (THA). Our one-year results demonstrated elevation in metal ion levels above baseline with no significant difference between the CoM and MoM groups. This paper reviews the five-year data.
Patients And Methods: The implants used in each patient differed only in respect to the type of femoral head (ceramic or metal). At five-year follow-up of the 83 enrolled patients, data from 67 (36 CoM, 31 MoM) was available for comparison.
Results: The mean serum cobalt (Co) and chromium (Cr) ion levels remained above baseline in both groups (CoM: Co 1.16 μg/l (0.41 to 14.67), Cr 1.05 μg/l (0.16 to 12.58); MoM: Co 2.93 μg/l (0.35 to 30.29), Cr 1.85 μg/l (0.36 to 17.00)) but the increase was significantly less in the CoM cohort (Co difference p = 0.001, Cr difference p = 0.002). These medium-term results, coupled with lower revision rates from national joint registries, suggest that the performance of CoM THA may be superior to that of MoM.
Conclusion: While both bearing combinations have since been withdrawn these results provide useful information for planning clinical surveillance of CoM THAs and warrants continued monitoring. Cite this article: 2017;99-B:1298-1303.
Long-term follow-up of ceramic-on-metal total hip arthroplasty.
Baker G, Hill J, ONeill F, McChesney J, Stevenson M, Beverland D Bone Jt Open. 2024; 5(11):971-976.
PMID: 39496282 PMC: 11534456. DOI: 10.1302/2633-1462.511.BJO-2024-0087.R1.
Perka C, Mohaddes M, Zagra L, Ekkernkamp A, Keller N, Stengel D EFORT Open Rev. 2024; 9(7):632-645.
PMID: 38949170 PMC: 11297405. DOI: 10.1530/EOR-23-0218.
Prosthetic Metals: Release, Metabolism and Toxicity.
Zhong Q, Pan X, Chen Y, Lian Q, Gao J, Xu Y Int J Nanomedicine. 2024; 19:5245-5267.
PMID: 38855732 PMC: 11162637. DOI: 10.2147/IJN.S459255.
Merfort R, Maffulli N, Hofmann U, Hildebrand F, Simeone F, Eschweiler J Sci Rep. 2023; 13(1):20327.
PMID: 37989863 PMC: 10663607. DOI: 10.1038/s41598-023-47670-z.
Migliorini F, Pilone M, Bell A, Merfort R, Giorgino R, Maffulli N Sci Rep. 2023; 13(1):6918.
PMID: 37106086 PMC: 10140036. DOI: 10.1038/s41598-023-34177-w.